XRAY vs. MMSI, ICUI, HAE, QDEL, NEOG, STAA, CERS, OSUR, ANIK, and UTMD
Should you be buying DENTSPLY SIRONA stock or one of its competitors? The main competitors of DENTSPLY SIRONA include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry.
DENTSPLY SIRONA vs.
Merit Medical Systems (NASDAQ:MMSI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.
DENTSPLY SIRONA received 29 more outperform votes than Merit Medical Systems when rated by MarketBeat users. However, 69.91% of users gave Merit Medical Systems an outperform vote while only 60.98% of users gave DENTSPLY SIRONA an outperform vote.
In the previous week, Merit Medical Systems had 8 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 21 mentions for Merit Medical Systems and 13 mentions for DENTSPLY SIRONA. Merit Medical Systems' average media sentiment score of 0.82 beat DENTSPLY SIRONA's score of 0.49 indicating that Merit Medical Systems is being referred to more favorably in the media.
Merit Medical Systems has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.
Merit Medical Systems has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.
Merit Medical Systems presently has a consensus target price of $110.78, suggesting a potential upside of 5.76%. DENTSPLY SIRONA has a consensus target price of $23.33, suggesting a potential upside of 49.86%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Merit Medical Systems.
Merit Medical Systems has a net margin of 9.05% compared to DENTSPLY SIRONA's net margin of -10.59%. Merit Medical Systems' return on equity of 15.61% beat DENTSPLY SIRONA's return on equity.
99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 3.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Merit Medical Systems beats DENTSPLY SIRONA on 15 of the 19 factors compared between the two stocks.
Get DENTSPLY SIRONA News Delivered to You Automatically
Sign up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DENTSPLY SIRONA Competitors List
Related Companies and Tools
This page (NASDAQ:XRAY) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy XRAY Stock Free XRAY Stock Alerts